PremiumRatingsQuest Diagnostics: Strong Growth Potential and Resilience Amidst Economic Uncertainty Quest Diagnostics price target raised to $190 from $182 at Truist Quest Diagnostics price target raised to $194 from $191 at Baird PremiumThe FlyEarly notable gainers among liquid option names on April 22nd Quest Diagnostics: Strong Q1 Performance and Positive Outlook Support Buy Rating Quest Diagnostics backs FY25 adjusted EPS view $9.55-$9.80, consensus $9.69 PremiumThe FlyQuest Diagnostics price target raised to $189 from $178 at Mizuho Quest Diagnostics initiated with a Buy at Redburn Atlantic Quest Diagnostics: Steady Growth and Strategic Advancements Justify Buy Rating 
